Effectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 – A Comparison of Two Methods; Germany, 2009/10
Helmut Uphoff, Udo Buchholz(Robert Koch Institute), Ole Wichmann(Robert Koch Institute), Marcel Feig(Robert Koch Institute), Doris Altmann, Tim Eckmanns(Robert Koch Institute), Brunhilde Schweiger(National Influenza Center), Walter Haas(Robert Koch Institute), Martina Littmann(Landesamt für Gesundheit und Soziales), Carina Helmeke(Landesamt für Natur, Umwelt und Klima Nordrhein-Westfalen), Daniel Faensen(Robert Koch Institute), Dietmar Beier(Landesuntersuchungsanstalt Sachsen), Matthias an der Heiden(Robert Koch Institute), Hartmut Campe(Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit), Silke Buda(Robert Koch Institute)
Cited by 13
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Neurological complications of dengue virus infection
|The Lancet Neurology|2013|500